Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies

Cytometry. Part B, Clinical Cytometry
Prashant R TembharePapagudi G Subramanian

Abstract

Current flow-cytometric plasma cell (PC) gating is based on CD138, CD38, and CD45 expression. CD138 is known for variable expression and loss during storage and processing. Introduction of anti-CD38 and anti-CD138 monoclonal-antibody therapies has limited the use of these markers during follow-up. Hence, additional reliable PC-gating markers are required. Recently, CD229 has been claimed as an alternative PC-gating marker. However, these studies are limited to a small cohort of samples. We evaluated the utility of CD229 as a new PC-gating marker in routine laboratory practice. Expression of CD229 was studied in 310 bone marrow (BM) samples (251 plasma-cell disorders and 59 controls) and compared with CD138 and CD38 expression. We also evaluated the effect of additional processing for cytoplasmic immunoglobulin-light-chains (CyIgL) staining on the quantitation of PC. Expression of CD229 was consistently stronger on PC than other hematopoietic-cells (p < 0.001). PC-percentages using CD229 in combination with CD38 or CD138 and CD45 revealed high correlation with a reference gating-strategy using CD138, CD38 and CD45 (r = 0.98, r = 0.99 r = 0.99 respectively) and r = 0.92 using CD229 and CD45 without CD38 or CD138. In contrast, CD1...Continue Reading

References

Apr 1, 1997·British Journal of Haematology·A C RawstronG J Morgan
Feb 24, 2005·British Journal of Haematology·Roger G Owen, Andy C Rawstron
Feb 13, 2008·Haematologica·Andy C RawstronUNKNOWN European Myeloma Network
Sep 5, 2008·Current Protocols in Cytometry·Andy C Rawstron
Oct 3, 2009·Leukemia·R FonsecaUNKNOWN International Myeloma Working Group
May 4, 2010·British Journal of Haematology·George Grigoriadis, Susan Whitehead
Nov 30, 2010·Best Practice & Research. Clinical Haematology·Shaji KumarWilliam Morice
May 25, 2011·Haematologica·Djordje AtanackovicNicolaus Kröger
Oct 1, 2011·Leukemia & Lymphoma·Valdas PeceliunasLaimonas Griskevicius
Jun 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andy C RawstronRoger G Owen
Jan 5, 2014·Blood·Ildikó FrigyesiBjörn Nilsson
Feb 22, 2014·Expert Opinion on Investigational Drugs·Jacob P LaubachKenneth C Anderson
Oct 9, 2014·Blood Reviews·Daniel W SherbenouBin Liu
Jul 2, 2015·Cytometry. Part B, Clinical Cytometry·Fanny PojeroUNKNOWN EuroFlow group
Jul 21, 2015·Bone Marrow Transplantation·A M SherrodR F Cornell
Sep 13, 2015·Blood Reviews·Tomas Jelinek, Roman Hajek
Dec 17, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marta CuencaPablo Engel
Aug 22, 2017·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Gaurav ChatterjeePrashant R Tembhare

❮ Previous
Next ❯

Citations

May 8, 2018·Cytometry. Part B, Clinical Cytometry·Paul K Wallace
Oct 6, 2020·Cytometry. Part B, Clinical Cytometry·Kah Teong SohPaul K Wallace

❮ Previous
Next ❯